The GCK-MODY group had an earlier onset (higher glucose at threshold of glucagon release; p = 0.007) and greater peak glucagon response (p = 0.03) than the T2D group (Table 2a and Figure 1C). The gene discussed is GCK; the disease is type 2 diabetes mellitus.